Immunobrain Checkpoint
ImmunoBrain Checkpoint (IBC) is a clinical stage biopharmaceutical company transforming the fight against neurodegeneration and aging by targeting the immune system, restoring brain immune communications and boosting natural repair mechanisms. IBC’s lead program is a proprietary antibody targeting the inhibitory immune checkpoint pathway PD-1/PD-L1, to treat Alzheimer's disease. IBC's novel approach for the treatment of neurodegeneration is based on years of innovative, cutting-edge scientific discoveries made in the lab of Prof. Michal Schwartz at the Weizmann Institute of Science.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
18
11 to 50 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
5
organic / mo
Sign up free to see all 1 verified contacts at Immunobrain Checkpoint
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
- SB
Shai Braiman
Researcher · Science
EmailPhone
Showing 1 of 1 verified contacts
Top roles at Immunobrain Checkpoint
1 distinct titles indexed · top 1 shown.
- 1researcher
Sign up to unlock all 1 contacts at Immunobrain Checkpoint
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Immunobrain Checkpoint
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.